Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Mesa Laboratories (MLAB) over the last 15 years, with Q1 2025 value amounting to $52000.0.

  • Mesa Laboratories' Non-cash Items rose 10000.0% to $52000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $52000.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $52000.0 for FY2025, which is 10000.0% up from last year.
  • According to the latest figures from Q1 2025, Mesa Laboratories' Non-cash Items is $52000.0, which was up 10000.0% from $287000.0 recorded in Q4 2024.
  • In the past 5 years, Mesa Laboratories' Non-cash Items registered a high of $37.6 million during Q4 2021, and its lowest value of $26000.0 during Q1 2024.
  • For the 5-year period, Mesa Laboratories' Non-cash Items averaged around $13.0 million, with its median value being $3.4 million (2022).
  • As far as peak fluctuations go, Mesa Laboratories' Non-cash Items plummeted by 9874.64% in 2023, and later surged by 10000.0% in 2025.
  • Mesa Laboratories' Non-cash Items (Quarter) stood at $37.6 million in 2021, then crashed by 90.94% to $3.4 million in 2022, then plummeted by 96.51% to $119000.0 in 2023, then surged by 141.18% to $287000.0 in 2024, then plummeted by 81.88% to $52000.0 in 2025.
  • Its Non-cash Items was $52000.0 in Q1 2025, compared to $287000.0 in Q4 2024 and $229000.0 in Q3 2024.